Home  /  Resource Library  /  Clinical outcomes of tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma: insights from a single-center study

Clinical outcomes of tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma: insights from a single-center study

Real world study of CAR-T tisagenlecleucel for treatment of relapsed DLBCL